Cleared Special

K060418 - 8F SHERPA NX GUIDE CATHETER

K060418 is the FDA 510(k) clearance for 8F SHERPA NX GUIDE CATHETER by Medtronic Vascular. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Special 510(k) pathway after a 26-day FDA review.

K060418 · Medtronic Vascular · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2006
Decision
26d
Days
Class 2
Risk

K060418 is an FDA 510(k) clearance for the 8F SHERPA NX GUIDE CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Medtronic Vascular (Danvers, US). The FDA issued a Cleared decision on March 15, 2006 after a review of 26 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Medtronic Vascular devices

Submission Details

510(k) Number K060418 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 17, 2006
Decision Date March 15, 2006
Days to Decision 26 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
99d faster than avg
Panel avg: 125d · This submission: 26d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 573
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K060418.
SCOUTPRO 7F CORONARY SINUS LEAD DELIVERY SYSTEM
K060807 · Biotronik, Inc. · Apr 2006
VASCULAR SOLUTIONS TWIN-PASS DUAL ACCESS CATHETER AND SKYWAY SUPPORT CATHETER
K060327 · Vascular Solutions, Inc. · Apr 2006
SCOUTPRO 8F, MODELS 342 262
K060655 · Biotronik, Inc. · Apr 2006
MODIFICATION TO POLARCATH PERIPHERAL DILATATION SYSTEM
K060572 · Boston Scientific Corporation · Mar 2006
CPS AIM INNER CATHETER, MODELS 410140, 410141, 410142, 410144, 410145, 410146, 410147, 410148
K053217 · St Jude Medical · Mar 2006
CPS DIRECT SL OUTER CATHETER
K053277 · St Jude Medical · Feb 2006